Literature DB >> 15025725

Molecular diagnosis of hereditary hemochromatosis: application of a newly-developed reverse-hybridization assay in the South African population.

M J Kotze1, J N P de Villiers, C S H Bouwens, L Warnich, M G Zaahl, S van der Merwe, C Oberkanins.   

Abstract

A recently developed strip-assay for hemochromatosis provides a rapid method for simultaneous detection of multiple mutations, which among others includes the HFE gene mutations V53M, V59M, H63D, H63H, S65C, Q127H, E168Q, and C282Y, previously detected in the general South African population using gel-based mutation-screening methods. The objective of the study was to determine the frequency of the relatively rare mutations in samples selected for altered iron parameters or a family history of hereditary hemochromatosis (HH) as part of the validation process of the assay for routine diagnostic purposes. The study population consisted of 451 individuals previously screened for mutations C282Y and H63D by restriction enzyme analysis in order to confirm or possibly exclude a diagnosis of HH. These individuals were subjected to mutation screening using the commercially available hemochromatosis strip-assay. Previous positive results for mutations C282Y and H63D in 233 individuals confirmed the accuracy of the reverse-hybridization assay. Mutation S65C was detected in 13 Caucasians, including three compound heterozygotes. These constituted 2% (13/600) of the chromosomes without mutations C282Y or H63D. The African-specific HFE mutation V53M was detected in one out of 11 (9%) African subjects screened. Mutation E168Q was detected in a single Caucasian individual together with mutation H63D. Our data demonstrate the value of the strip-based technology in providing a rapid and reliable comprehensive test for simultaneous analysis of multiple mutations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15025725     DOI: 10.1111/j.1399-0004.2004.00222.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

1.  Impact of HFE gene variants on iron overload, overall survival and leukemia-free survival in myelodysplastic syndromes.

Authors:  Mathias Schneeweiss-Gleixner; Georg Greiner; Susanne Herndlhofer; Julia Schellnegger; Maria-Theresa Krauth; Karoline V Gleixner; Friedrich Wimazal; Corinna Steinhauser; Michael Kundi; Renate Thalhammer; Ilse Schwarzinger; Gregor Hoermann; Harald Esterbauer; Manuela Födinger; Peter Valent; Wolfgang R Sperr
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

2.  Analysis of genes implicated in iron regulation in individuals presenting with primary iron overload.

Authors:  Monique G Zaahl; Alison T Merryweather-Clarke; Maritha J Kotze; Schalk van der Merwe; Louise Warnich; Kathryn J H Robson
Journal:  Hum Genet       Date:  2004-08-24       Impact factor: 4.132

3.  HFE gene mutations increase the risk of coronary heart disease in women.

Authors:  M Carolina Pardo Silva; Omer T Njajou; Behrooz Z Alizadeh; Albert Hofman; Jacqueline C M Witteman; Cornelia M van Duijn; A Cecile J W Janssens
Journal:  Eur J Epidemiol       Date:  2010-07-18       Impact factor: 8.082

Review 4.  Heart failure in sub-Saharan Africa.

Authors:  Gerald S Bloomfield; Felix A Barasa; Jacob A Doll; Eric J Velazquez
Journal:  Curr Cardiol Rev       Date:  2013-05

5.  Pathogenic Mechanisms Underlying Iron Deficiency and Iron Overload: New Insights for Clinical Application.

Authors:  M J Kotze; D P van Velden; S J van Rensburg; R Erasmus
Journal:  EJIFCC       Date:  2009-08-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.